ST雲投(002200.SZ):聯合體中標雲南省重大傳染病救治能力和疾控機構核心能力提升工程工程總承包(FEPC)項目
格隆匯 9 月 22日丨ST雲投(002200.SZ)公佈,近日,公司收到招標代理機構雲南西南招標有限公司發來的《中標通知書》,確定公司參與的聯合體為“雲南省重大傳染病救治能力和疾控機構核心能力提升工程工程總承包(FEPC)”項目中標人。
該項目招標人為雲南省社會事業發展有限公司,聯合體牽頭人為雲南雲投建設有限公司,均為公司控股股東雲投集團的控股子公司。在收到《中標通知書》後,公司將與雲南省社會事業發展有限公司簽訂《項目總承包合同》,同時與雲南雲投建設有限公司簽訂《聯合體協議》。
該項目總投資估算80.14億元,依據投標文件和聯合體成員協商確定,公司作為聯合體成員之一,按照投標文件及實施方案要求,負責實施該項目的醫院改造及疾控中心改造工程,具體實施範圍以發包人確認的施工圖紙中改造工程範圍確定。施工金額依照聯合體中標的價格體系,具體以相關合同或協議約定為準。項目若能順利實施,將對公司2020年及未來年度經營業績產生積極的影響,影響金額以最終審計結算金額為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.